202 related articles for article (PubMed ID: 36820593)
1. SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study.
Sapronova K; Kaķe R; Pavāre J; Grāvele D; Šēla I; Ērgle E; Isarova D; Grīnberga Z; Zavadska D
Medicine (Baltimore); 2023 Feb; 102(6):e32795. PubMed ID: 36820593
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States.
Levorson RE; Christian E; Hunter B; Sayal J; Sun J; Bruce SA; Garofalo S; Southerland M; Ho S; Levy S; Defillipi C; Peake L; Place FC; Hourigan SK
PLoS One; 2021; 16(11):e0259823. PubMed ID: 34748615
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.
Dimopoulou D; Kyritsi M; Dadouli K; Vergadi E; Tsiligianni E; Papadimitriou E; Mavridi A; Giannakopoulos S; Tsiourvopoulou G; Palyvou M; Angeli E; Brikos N; Eleftheriou I; Spoulou V; Michos A; Gkentzi D; Siomou E; Papaevangelou V; Grivea I; Syrogiannopoulos G; Galanakis E; Hadjichristodoulou C; Tsolia M
Eur J Pediatr; 2023 Jan; 182(1):439-449. PubMed ID: 36383284
[TBL] [Abstract][Full Text] [Related]
4. The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.
Lee J; Choe YJ; Minn D; Kim JH
J Korean Med Sci; 2022 Nov; 37(44):e314. PubMed ID: 36377292
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
[TBL] [Abstract][Full Text] [Related]
6. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Seroprevalence in Florida Department of Health in Palm Beach County Obstetric Clinics: A Cross-Sectional Study during the First Pandemic Surge.
Gonik CO; Alonso AM; Gonik B
Am J Perinatol; 2023 Jun; 40(8):912-916. PubMed ID: 34758496
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Seroprevalence in Children from Western Romania, March to June 2021.
Olariu TR; Craciun AC; Vlad DC; Dumitrascu V; Pop LL; Horhat F; Lupu MA
Vector Borne Zoonotic Dis; 2022 Apr; 22(4):267-270. PubMed ID: 35384727
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G;
J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
Lewin A; De Serres G; Grégoire Y; Perreault J; Drouin M; Fournier MJ; Tremblay T; Beaudoin J; Boivin A; Goyette G; Finzi A; Bazin R; Germain M; Delage G; Renaud C
Can J Public Health; 2022 Jun; 113(3):385-393. PubMed ID: 35380364
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population.
Smirnov VS; Lyalina LV; Milichkina AM; Khamitova IV; Zueva EV; Ivanov VA; Zaguzov VS; Totolian AA
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632653
[TBL] [Abstract][Full Text] [Related]
19. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia.
Mahallawi WH; Alsarani MA; Aljohani RH; Alluhaibi AA; Alamri TH; Ibrahim NA; Mahallawi KH; Khabourd OF
Ann Saudi Med; 2022; 42(2):69-74. PubMed ID: 35380058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
